These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10570439)

  • 21. Survival of patients with transitional cell carcinoma of the ureter and renal pelvis in Balkan endemic nephropathy and non-endemic areas of Serbia.
    Dragicevic D; Djokic M; Pekmezovic T; Micic S; Hadzi-Djokic J; Vuksanovic A; Simic T
    BJU Int; 2007 Jun; 99(6):1357-62. PubMed ID: 17346272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract.
    Kang CH; Yu TJ; Hsieh HH; Yang JW; Shu K; Huang CC; Chiang PH; Shiue YL
    Cancer; 2003 Oct; 98(8):1620-6. PubMed ID: 14534877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma.
    Yashima K; Milchgrub S; Gollahon LS; Maitra A; Saboorian MH; Shay JW; Gazdar AF
    Clin Cancer Res; 1998 Jan; 4(1):229-34. PubMed ID: 9516976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of human telomerase RNA in the tumour-surrounding mucosa of bladder carcinomas as a marker for premalignant transformation.
    Leuenroth S; Riethdorf S; Erbersdobler A; Riethdorf L; Löning T; Huland H; Friedrich MG
    BJU Int; 2005 Sep; 96(4):553-7. PubMed ID: 16104909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
    Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of stathmin in localized upper urinary tract urothelial carcinoma: correlations with prognosis.
    Lin WC; Chen SC; Hu FC; Chueh SC; Pu YS; Yu HJ; Huang KH
    Urology; 2009 Dec; 74(6):1264-9. PubMed ID: 19800106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telomerase in (pre)neoplastic cervical disease.
    Wisman GB; De Jong S; Meersma GJ; Helder MN; Hollema H; de Vries EG; Keith WN; van der Zee AG
    Hum Pathol; 2000 Oct; 31(10):1304-12. PubMed ID: 11070123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter.
    Kamijima S; Tobe T; Suyama T; Ueda T; Igarashi T; Ichikawa T; Ito H
    Int J Urol; 2005 Nov; 12(11):941-7. PubMed ID: 16351648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of cyclooxygenase-2 and EP4 receptor in transitional cell carcinoma of the upper urinary tract.
    Miyata Y; Kanda S; Nomata K; Eguchi J; Kanetake H
    J Urol; 2005 Jan; 173(1):56-60. PubMed ID: 15592025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical evaluation of p53 oncoprotein in transitional cell carcinoma of the upper urinary tract.
    Nakanishi K; Kawai T; Torikata C
    Hum Pathol; 1996 Dec; 27(12):1336-40. PubMed ID: 8958308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas.
    Yashima K; Litzky LA; Kaiser L; Rogers T; Lam S; Wistuba II; Milchgrub S; Srivastava S; Piatyszek MA; Shay JW; Gazdar AF
    Cancer Res; 1997 Jun; 57(12):2373-7. PubMed ID: 9192812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The study on the correlation between telomerase and histopathologic features of retinoblastoma].
    Ren RJ; Li B; Sun XL; Zheng BH; Li LQ; Chen CX
    Zhonghua Yan Ke Za Zhi; 2004 Apr; 40(4):234-8. PubMed ID: 15268829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
    Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
    Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of open nephroureterectomy and open conservative management of upper urinary tract transitional cell carcinoma.
    Dragicevic D; Djokic M; Pekmezovic T; Vuksanovic A; Micic S; Hadzi-Djokic J; Tulic C; Milenkovic D; Pljesa-Ercegovac M; Simic T
    Urol Int; 2009; 82(3):335-40. PubMed ID: 19440024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of telomerase and its RNA in nasopharyngeal carcinoma].
    Wen Z; Xiao J; Tang F; Tian Y; Zhao S; Chen B
    Chin Med J (Engl); 2000 Jun; 113(6):525-8. PubMed ID: 11775871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?
    Brown GA; Busby JE; Wood CG; Pisters LL; Dinney CP; Swanson DA; Grossman HB; Pettaway CA; Munsell MF; Kamat AM; Matin SF
    BJU Int; 2006 Dec; 98(6):1176-80. PubMed ID: 17125474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract.
    Ohtsuka Y; Kawakami S; Fujii Y; Koga F; Saito K; Ando N; Takizawa T; Kageyama Y; Kihara K
    BJU Int; 2006 Jun; 97(6):1322-6. PubMed ID: 16686732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship among telomerase activity, telomerase RNA and telomerase catalytic subunit gene expression and their significance in non small-cell lung cancer].
    Wang J; Liu X; Jiang W
    Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):289-92. PubMed ID: 11783109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
    Tzai TS; Tsai YS; Chow NH
    Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.